Page 34 - Read Online

Page 16 of 19 Khokhar et al. Mini-invasive Surg 2022;6:2 https://dx.doi.org/10.20517/2574-1225.2021.97

PubMed
50. Eggebrecht H, Vaquerizo B, Moris C, et al; European Registry on Emergent Cardiac Surgery during TAVI (EuRECS-TAVI).
Incidence and outcomes of emergent cardiac surgery during transfemoral transcatheter aortic valve implantation (TAVI): insights
from the European Registry on Emergent Cardiac Surgery during TAVI (EuRECS-TAVI). Eur Heart J 2018;39:676-84. DOI
PubMed
51. Ibebuogu UN, Giri S, Bolorunduro O, et al. Review of reported causes of device embolization following trans-catheter aortic valve
implantation. Am J Cardiol 2015;115:1767-72. DOI PubMed
52. Nkomo VT, Suri RM, Pislaru SV, et al. Delayed transcatheter heart valve migration and failure. JACC Cardiovasc Imaging
2014;7:960-2. DOI PubMed
53. Radu C, Raffoul R, Brochet E, Himbert D. Delayed migration of a transfemorally implanted aortic bioprosthesis. J Thorac
Cardiovasc Surg 2012;143:e1-3. DOI PubMed
54. Vendrik J, van den Boogert TPW, Koch KT, Baan J Jr. Balloon-expandable TAVR prosthesis dislocates into the ascending aorta.
JACC Case Rep 2019;1:101-4. DOI PubMed PMC
55. Fournier S, Monney P, Roguelov C, et al. How should I treat an Edwards SAPIEN 3 aortic valve embolisation during a transaortic
transcatheter aortic valve implantation? EuroIntervention 2017;13:495-8. DOI PubMed
56. Ussia GP, Barbanti M, Ramondo A, et al. The valve-in-valve technique for treatment of aortic bioprosthesis malposition an analysis
of incidence and 1-year clinical outcomes from the italian CoreValve registry. J Am Coll Cardiol 2011;57:1062-8. DOI PubMed
57. Alkhouli M, Sievert H, Rihal CS. Device embolization in structural heart interventions: incidence, outcomes, and retrieval techniques.
JACC Cardiovasc Interv 2019;12:113-26. DOI PubMed
58. Tay EL, Gurvitch R, Wijeysinghe N, et al. Outcome of patients after transcatheter aortic valve embolization. JACC Cardiovasc Interv
2011;4:228-34. DOI PubMed
59. Ribeiro HB, Nombela-Franco L, Urena M, et al. Coronary obstruction following transcatheter aortic valve implantation: a systematic
review. JACC Cardiovasc Interv 2013;6:452-61. DOI PubMed
60. Ribeiro HB, Webb JG, Makkar RR, et al. Predictive factors, management, and clinical outcomes of coronary obstruction following
transcatheter aortic valve implantation: insights from a large multicenter registry. J Am Coll Cardiol 2013;62:1552-62. DOI PubMed
61. Dvir D, Leipsic J, Blanke P, et al. Coronary obstruction in transcatheter aortic valve-in-valve implantation: preprocedural evaluation,
device selection, protection, and treatment. Circ Cardiovasc Interv 2015;8:e002079. DOI PubMed
62. Jabbour RJ, Tanaka A, Finkelstein A, et al. Delayed coronary obstruction after transcatheter aortic valve replacement. J Am Coll
Cardiol 2018;71:1513-24. DOI PubMed
63. Ribeiro HB, Rodés-Cabau J, Blanke P, et al. Incidence, predictors, and clinical outcomes of coronary obstruction following
transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry. Eur Heart J
2018;39:687-95. DOI PubMed
64. De Marco F, Casenghi M, Spagnolo P, et al. A patient-specific algorithm to achieve commissural alignment with Acurate Neo: the
sextant technique. Catheter Cardiovasc Interv 2021;98:E847-54. DOI PubMed
65. Tang GHL, Zaid S, Fuchs A, et al. Alignment of transcatheter aortic-valve neo-commissures (ALIGN TAVR): impact on final valve
orientation and coronary artery overlap. JACC Cardiovasc Interv 2020;13:1030-42. DOI PubMed
66. Kitamura M, Wilde J, Gohmann R, et al. Commissural alignment of the ACURATE neo valve in transcatheter aortic valve
replacement. JACC Cardiovasc Interv 2021;14:1740-2. DOI PubMed
67. Wong I, Bieliauskas G, De Backer O, Søndergaard L. Technical considerations for transcatheter aortic valve replacement with
ACURATE neo2. JACC Cardiovasc Interv 2021;14:224-6. DOI PubMed
68. Mercanti F, Rosseel L, Neylon A, et al. Chimney stenting for coronary occlusion during TAVR: insights from the chimney registry.
JACC Cardiovasc Interv 2020;13:751-61. DOI PubMed
69. Palmerini T, Chakravarty T, Saia F, et al. Coronary protection to prevent coronary obstruction during TAVR: a multicenter
international registry. JACC Cardiovasc Interv 2020;13:739-47. DOI PubMed
70. Abramowitz Y, Chakravarty T, Jilaihawi H, et al. Clinical impact of coronary protection during transcatheter aortic valve
implantation: first reported series of patients. EuroIntervention 2015;11:572-81. DOI PubMed
71. Pighi M, Lunardi M, Pesarini G, et al. Intravascular ultrasound assessment of coronary ostia following valve-in-valve transcatheter
aortic valve implantation. EuroIntervention 2021;16:1148-51. DOI PubMed
72. Khan JM, Greenbaum AB, Babaliaros VC, et al. The BASILICA trial: prospective multicenter investigation of intentional leaflet
laceration to prevent TAVR coronary obstruction. JACC Cardiovasc Interv 2019;12:1240-52. DOI PubMed PMC
73. Lederman RJ, Babaliaros VC, Rogers T, et al. Preventing coronary obstruction during transcatheter aortic valve replacement: from
computed tomography to BASILICA. JACC Cardiovasc Interv 2019;12:1197-216. DOI PubMed PMC
74. Khan JM, Dvir D, Greenbaum AB, et al. Transcatheter laceration of aortic leaflets to prevent coronary obstruction during
transcatheter aortic valve replacement: concept to first-in-human. JACC Cardiovasc Interv 2018;11:677-89. DOI PubMed PMC
75. Komatsu I, Mackensen GB, Aldea GS, Reisman M, Dvir D. Bioprosthetic or native aortic scallop intentional laceration to prevent
iatrogenic coronary artery obstruction. Part 2: how to perform BASILICA. EuroIntervention 2019;15:55-66. DOI PubMed
76. Komatsu I, Tang GHL, Leipsic J, et al. Distribution of C-arm projections in native and bioprosthetic aortic valves cusps: implication
for BASILICA procedures. Catheter Cardiovasc Interv 2021;97:E580-7. DOI PubMed
77. Tang GHL, Komatsu I, Tzemach L, et al. Risk of coronary obstruction and the need to perform BASILICA: the VIVID classification.
EuroIntervention 2020;16:e757-9. DOI PubMed
78. Khan JM, Babaliaros VC, Greenbaum AB, et al. Preventing coronary obstruction during transcatheter aortic valve replacement: